We are pleased to announce that Morgan Lewis partner Jacqueline Berman will speak at the Food and Drug Law Institute’s Introduction to Biologics and Biosimilars Law and Regulation.
Regulations of Biological Marketing
Wednesday, April 1, 2020 | 11:15 am–12:30 pm
This course will explore the regulation of biological products, including biotechnology-derived therapeutic proteins, human tissue, gene, and cell products. The discussion will include the abbreviated pathway to market for biosimilar biological products and associated intellectual property issues, including exclusivity and biologics patent litigation.
CLE credit: FDLI applies for CLE credits in Ohio, Pennsylvania, and Virginia. These CLE approvals may also be honored by other states; please check with your bar association for guidance. The CLE credits will be posted as they are granted and you can request to be notified when approval is received.